The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| INSEEGO CORP | Note 5.500% 6/1 | 45782BAA2 | 13,991 | 13,700,000 | PRN | DFND | 0 | 0 | 13,700,000 | ||
| INSEEGO CORP | COMMON | 45782B104 | 105,434 | 21,965,504 | SH | DFND | 0 | 0 | 21,965,504 | ||
| MEDICINES CO | COMMON | 584688105 | 5,750 | 115,000 | SH | DFND | 1 | 0 | 0 | 115,000 | |
| MEDICINES CO | COMMON | 584688105 | 5 | 100 | SH | DFND | 0 | 0 | 100 | ||
| MIRATI THERAPEUTICS INC | COMMON | 60468T105 | 244,323 | 3,135,966 | SH | DFND | 1 | 0 | 0 | 3,135,966 | |
| SOLID BIOSCIENCES INC. | COMMON | 83422E105 | 119 | 11,488 | SH | DFND | 1 | 0 | 0 | 11,488 | |